10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000721371-22-000013`
Period End Date	20211231
Filing Date	20220203
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	cah-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 92 Cash Flow Statement 68 Stockholders Equity 57 Comprehensive Income 28

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.16B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.41B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$9.10B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$9.41B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$14.94B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	50.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	36.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$14.59B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$4.34B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.84B	USD	Point-in-time
Total assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Total assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$1.10B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.85B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.05B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.32B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$10.09B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$8.60B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$951.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$913.00M	USD	Point-in-time
Total assets	`Assets`	$43.68B	USD	Point-in-time
Total assets	`Assets`	$44.45B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$24.76B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$23.70B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$301.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$871.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.96B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.67B	USD	Point-in-time
Disposal Group, Including Discontinued Operation, Liabilities	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Disposal Group, Including Discontinued Operation, Liabilities	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	$96.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.62B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.73B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.37B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.34B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$9.61B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$9.67B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2021 and June 30, 2021	`CommonStockValue`	$2.72B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2021 and June 30, 2021	`CommonStockValue`	$2.81B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.25B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.21B	USD	Point-in-time
Common shares in treasury, at cost: 50 million shares and 36 million shares at December 31, 2021 and June 30, 2021, respectively	`TreasuryStockValue`	$2.19B	USD	Point-in-time
Common shares in treasury, at cost: 50 million shares and 36 million shares at December 31, 2021 and June 30, 2021, respectively	`TreasuryStockValue`	$2.88B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-85.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-34.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$998.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$1.79B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$4.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$44.45B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$43.68B	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	50.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	36.00M	shares	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$45.46B	USD	1 Quarter
Revenue	`Revenues`	$41.54B	USD	1 Quarter
Revenue	`Revenues`	$80.61B	USD	2 Qtrs
Revenue	`Revenues`	$89.42B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$43.84B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$77.11B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$39.77B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$86.17B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.78B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.62B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.26B	USD	2 Qtrs
Gross margin	`GrossProfit`	$3.49B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.28B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.27B	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$25.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$20.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$7.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$57.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$116.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$158.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$79.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$234.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-52.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-32.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-1.07B	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-34.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-950.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-163.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-535.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$461.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$19.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$17.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$13.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$12.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$77.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$37.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$91.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$46.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-604.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-236.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$427.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-973.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-1.02B	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-203.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-613.00M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-925.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$320.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$376.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$49.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$629.00M	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.13	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.28	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.17	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.14	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.13	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.17	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.12	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.27	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	294.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	283.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	279.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	293.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	285.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	281.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	295.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	295.00M	shares	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.97	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.98	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.49	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.49	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$404.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$332.00M	USD	2 Qtrs
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
Gain/(Loss) on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$42.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$51.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$25.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$35.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$499.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$329.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.26B	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$361.00M	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.86B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.06B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.84B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-504.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$549.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.49B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$174.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$141.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$4.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$18.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$4.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$22.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	-	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$938.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$815.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-191.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$592.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$49.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-6.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-27.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$289.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$289.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$800.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-344.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.71B	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-11.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$14.00M	USD	2 Qtrs
Cash Reclassified from assets held for sale	`CashReclassifiedToAssetHeldForSale`	$109.00M	USD	2 Qtrs
Cash Reclassified from assets held for sale	`CashReclassifiedToAssetHeldForSale`	-	USD	2 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$966.00M	USD	2 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-246.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.16B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.41B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.16B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.41B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.77B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.74B	USD	Point-in-time

Stockholders Equity 57 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	50.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	36.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.19B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.88B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$49.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$630.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$320.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$376.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$49.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$629.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$34.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$34.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00M	USD	1 Quarter
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodSharesShareBasedCompensation`	1.00M	shares	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$46.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$19.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$30.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$800.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Dividends	`Dividends`	$139.00M	USD	1 Quarter
Dividends	`Dividends`	$280.00M	USD	2 Qtrs
Dividends	`Dividends`	$289.00M	USD	2 Qtrs
Dividends	`Dividends`	$144.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	2 Qtrs
Other	`StockholdersEquityOther`	$1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$-2.00M	USD	2 Qtrs
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.43B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	50.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	36.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.19B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.88B	USD	Point-in-time
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$800.00M	USD	2 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$300.00M	USD	1 Quarter

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$377.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$630.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-18.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-43.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$33.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$21.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-6.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-8.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$13.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$18.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$51.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$34.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-51.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$664.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$428.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$270.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$25.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$663.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$427.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$269.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.